Literature DB >> 30014585

Oxidized Albumin-A Trojan Horse for p38 MAPK-Mediated Inflammation in Decompensated Cirrhosis.

Francesca Cingolani1, Mark J Czaja1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30014585      PMCID： PMC6204090          DOI： 10.1002/hep.30164

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  10 in total

1.  Antioxidants in the treatment of chronic liver diseases: why is the efficacy evidence so weak in humans?

Authors:  Shelly C Lu
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

2.  Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.

Authors:  Joan Clària; Rudolf E Stauber; Minneke J Coenraad; Richard Moreau; Rajiv Jalan; Marco Pavesi; Àlex Amorós; Esther Titos; José Alcaraz-Quiles; Karl Oettl; Manuel Morales-Ruiz; Paolo Angeli; Marco Domenicali; Carlo Alessandria; Alexander Gerbes; Julia Wendon; Frederik Nevens; Jonel Trebicka; Wim Laleman; Faouzi Saliba; Tania M Welzel; Agustin Albillos; Thierry Gustot; Daniel Benten; François Durand; Pere Ginès; Mauro Bernardi; Vicente Arroyo
Journal:  Hepatology       Date:  2016-08-25       Impact factor: 17.425

Review 3.  Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis.

Authors:  Mauro Bernardi; Richard Moreau; Paolo Angeli; Bernd Schnabl; Vicente Arroyo
Journal:  J Hepatol       Date:  2015-07-17       Impact factor: 25.083

4.  Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen-Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis.

Authors:  José Alcaraz-Quiles; Mireia Casulleras; Karl Oettl; Esther Titos; Roger Flores-Costa; Marta Duran-Güell; Cristina López-Vicario; Marco Pavesi; Rudolf E Stauber; Vicente Arroyo; Joan Clària
Journal:  Hepatology       Date:  2018-10-13       Impact factor: 17.425

Review 5.  Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.

Authors:  Rita Garcia-Martinez; Paolo Caraceni; Mauro Bernardi; Pere Gines; Vicente Arroyo; Rajiv Jalan
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

Review 6.  Cell signaling in oxidative stress-induced liver injury.

Authors:  Mark J Czaja
Journal:  Semin Liver Dis       Date:  2007-11       Impact factor: 6.115

7.  Oxidative damage of albumin in advanced liver disease.

Authors:  Karl Oettl; Vanessa Stadlbauer; Franz Petter; Joachim Greilberger; Csilla Putz-Bankuti; Seth Hallström; Carolin Lackner; Rudolf E Stauber
Journal:  Biochim Biophys Acta       Date:  2008-05-01

8.  Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival.

Authors:  Karl Oettl; Ruth Birner-Gruenberger; Walter Spindelboeck; Hans Peter Stueger; Livia Dorn; Vanessa Stadlbauer; Csilla Putz-Bankuti; Peter Krisper; Ivo Graziadei; Wolfgang Vogel; Carolin Lackner; Rudolf E Stauber
Journal:  J Hepatol       Date:  2013-06-25       Impact factor: 25.083

Review 9.  Apoptosis signal-regulating kinase 1 as a therapeutic target.

Authors:  Yosuke Kawarazaki; Hidenori Ichijo; Isao Naguro
Journal:  Expert Opin Ther Targets       Date:  2014-03-24       Impact factor: 6.902

10.  The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.

Authors:  Rohit Loomba; Eric Lawitz; Parvez S Mantry; Saumya Jayakumar; Stephen H Caldwell; Hays Arnold; Anna Mae Diehl; C Stephen Djedjos; Ling Han; Robert P Myers; G Mani Subramanian; John G McHutchison; Zachary D Goodman; Nezam H Afdhal; Michael R Charlton
Journal:  Hepatology       Date:  2017-12-26       Impact factor: 17.425
  10 in total
  1 in total

1.  Perilipin 5 Protects against Cellular Oxidative Stress by Enhancing Mitochondrial Function in HepG2 Cells.

Authors:  Yanjie Tan; Yi Jin; Qian Wang; Jin Huang; Xiang Wu; Zhuqing Ren
Journal:  Cells       Date:  2019-10-11       Impact factor: 6.600
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.